[New therapeutic options in heart failure: the importance of the left ventricular ejection fraction].
心力衰竭的新治療選擇：左心室射血分數的重要性。
Ned Tijdschr Geneeskd 2023-02-16
Left Ventricular Systolic Function After 3 Months of SGLT2 Inhibitor Therapy in Heart Failure Patients with Reduced Ejection Fraction.
心力衰竭患者使用 SGLT2 抑制劑治療後3個月的左心室收縮功能。
J Cardiovasc Transl Res 2023-11-20
The Association of Ejection Fraction With Hospital-Associated Cardiac Arrest and Heart Failure Hospitalization Differs According to Baseline Estimated GFR.
射血分數與住院相關心臟驟停及心衰住院的關聯，根據基線估計腎功能不同而異。
Kidney Int Rep 2024-01-24
Impact of sodium glucose co-transporter-2 inhibitors on left atrial functions in patients with type-2 diabetes and heart failure with mildly reduced ejection fraction.
SGLT-2 抑制劑對2型糖尿病合併心臟衰竭且左心室射血分數輕度降低患者的左心房功能影響。
Int J Cardiol Heart Vasc 2024-01-09
Assessing the early prognosis of heart failure after acute myocardial infarction using left ventricular pressure-strain loop: a prospective randomized controlled clinical study.
使用左心室壓力-應變迴圈評估急性心肌梗塞後心力衰竭的早期預後：一項前瞻性隨機對照臨床研究。
Quant Imaging Med Surg 2024-02-29
Early SGLT2 inhibitor use is associated with improved left atrial strain following acute coronary syndrome.
急性冠狀動脈症候群後早期使用SGLT2抑制劑與改善左心房應變相關。
Acta Cardiol 2024-04-18
Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment.
糖尿病患者在 empagliflozin 治療後心臟肌肉應變和功率的改善。
J Diabetes Investig 2024-03-27
Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial.
Empagliflozin治療對住院心衰患者左心室射血分數範圍的影響 - 來自EMPULSE試驗的結果。
Eur J Heart Fail 2024-04-04
The effects of SGLT-2 inhibitors on echocardiographic indices and antioxidative properties in patients with heart failure with reduced ejection fraction and diabetes mellitus.
SGLT-2 抑制劑對於心臟射出分數降低及糖尿病患者的超聲心動圖指標和抗氧化特性的影響。
Eur Rev Med Pharmacol Sci 2024-09-04